A model to estimate the outcome of prostate cancer photodynamic therapy with TOOKAD soluble WST11

Physics in Medicine and Biology

Volumn 56, Issue 15, 2011, Pages 4771-4783

  Betrouni, Nacim ^a,b,c   Lopes, Renaud ^a   Puech, Philippe ^a,b,c   Colin, Pierre ^a,b,c   Mordon, Serge ^a,b,c  

^a INSERM   (France)

^b UNIV LILLE   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; DRUG DELIVERY; DRUG DOSAGE; MAGNETIC RESONANCE IMAGING; OPTICAL FIBERS; UROLOGY;

ACTION MODELING; IN-PHASE; MR IMAGES; PROSTATE CANCERS; RETROSPECTIVE ANALYSIS;

PHOTODYNAMIC THERAPY;

BACTERIOCHLOROPHYLL; WST11 COMPOUND;

ARTICLE; BIOLOGICAL MODEL; CHEMISTRY; DRUG EFFECT; HUMAN; MALE; METHODOLOGY; PATHOLOGY; PHOTOCHEMOTHERAPY; PROSTATE; PROSTATE TUMOR; RADIATION EXPOSURE; RETROSPECTIVE STUDY; SOLUBILITY; TIME; TREATMENT OUTCOME;

BACTERIOCHLOROPHYLLS; HUMANS; MALE; MODELS, BIOLOGICAL; PHOTOCHEMOTHERAPY; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SOLUBILITY; TIME FACTORS; TREATMENT OUTCOME;

EID: 79961059627     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/56/15/009     Document Type: Article

References (27)

1. Altschuler M D, Zhu T C, Li J and Hahn S M 2005 Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm Med. Phys. 32 3525-36
2. Arumainayagam N, Moore C M, Ahmed H U and Emberton M 2010 Photodynamic therapy for focal ablation of the prostate World J. Urol. 28 571-6
3. Chen Q, Wilson B C, Shetty S D, Patterson M S, Cerny J C and Hetzl F W 1997 Changes in in vivo optical properties and light distribution in normal canine prostate during photodynamic therapy Radiat. Res. 147 86-91 (Pubitemid 27014451)
4. Davidson S R H et al 2009 Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer Phys. Med. Biol. 54 2293-313
5. Dickey D J, Partridge K, Moore R B and Tulip J 2004 Light dosimetry for multiple cylindrical diffusing sources for use in photodynamic therapy Phys. Med. Biol. 49 3197-208 (Pubitemid 39140007)
6. Du K L et al 2006 Preliminary results of interstitial motexafin lutetium-mediated PDT for prostate cancer Lasers Surg. Med. 38 427-34
7. Eggener S E and Coleman J A 2008 Focal treatment of prostate cancer with vascular-targeted photodynamic therapy Sci. World J. 8 963-73
8. Fenning M C, Brown D Q and Chapman J D 1994 Photodosimetry of interstitial light delivery to solid tumours Med. Phys. 21 1149-56 (Pubitemid 24233843)
9. Haider M A et al 2007 Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide Radiology 244 196-204 (Pubitemid 46981974)
10. Johansson A, Axelsson J, Andersson-Engels S and Swartling J 2007 Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate Med. Phys. 34 4309-21 (Pubitemid 350029653)
11. Koudinova N V, Pinthus J H, Brandis A, Brenner O, Bendel P, Ramon J, Eshhar Z, Scherz A and Salomon Y 2003 Photodynamic therapy with Pd-bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenographs Int. J. Cancer 104 782-9 (Pubitemid 36418518)
12. Moore C M, Nathan T R, Lees W R, Mosse C A, Freeman A, Emberton M and Bown S G 2006 Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer Lasers Surg. Med. 38 356-63
13. Moore C M, Pendse D and Emberton M 2009 Photodynamic therapy for prostate cancer - a review of current status and future promise Nat. Clin. Pract. Urol. 6 18-30
14. Murrer L H, Marijnissen J P and Star W M 1996 Light distribution by linear diffusing sources for photodynamic therapy Phys. Med. Biol. 41 951-61 (Pubitemid 26180235)
15. Panteledis M L, Whitehurst C, Moore J V, King T A and Blacklock N J 1990 Photodynamic therapy for localised prostatic cancer-light penetration in the human prostate-gland J. Urol. 143 398-401 (Pubitemid 20066405)
16. Sloboda R S, Usmani N, Pedersen J, Murtha A, Pervez N and Yee D 2010 Time course of prostatic edema post permanent seed implant determined by magnetic resonance imaging Brachytherapy 9 354-61
17. Svensson T, Andersson-Engels S, Einarsdottir M and Svanberg K 2007 In vivo optical characterization of human prostate tissue using near-infrared time-resolved spectroscopy J. Biomed. Opt. 12 1-10
18. Swartling J, Axelsson J, Ahlgren G, Kälkner K M, Nilsson S, Svanberg S, Svanberg K and Andersson-Engels S 2010 System for interstitial photodynamic therapy with online dosimetry: first clinical experiences of prostate cancer J. Biomed. Opt. 15 058003
19. Tanaka O, Hayashi S, Matsuo M, Nakano M, Uno H, Ohtakara K, Miyoshi T, Degushi T and Hoshi H 2007 Effect of edema on postimplant dosimetry in prostate brachytherapy using CT/MRI fusion Int. J. Radiat. Oncol. Biol. Phys. 69 614-8 (Pubitemid 47380119)
20. Trachtenberg J et al 2007 Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response J. Urol. 178 1974-9 (Pubitemid 47554440)
21. Vollet-Filho J D, Menezes P F C, Moriyama L T, Grecco C, Sibata C, Allison R R, Castro O, Silva E and Bagnato V S Jr 2009 Possibility for a full optical determination of photodynamic therapy outcome J. Appl. Phys. 105 102038
22. Weersink R A, Bogaards A, Gertner M, Davidson S R H, Zhang K, Netchev G, Trachtenberg J and Wilson B C 2005 Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities J. Photochem. Photobiol., B 79 211-22 (Pubitemid 40668440)
23. Wilson B C, Whelan W, Davidson S R H, Weersink R A and Sherar M D 2002 Treatment planning platform for photodynamic therapy: architecture, function and validation Proc. SPIE 4612 85
24. Yan Y, Shu H, Bao X, Luo L and Va Y 1997 Clinical treatment planning optimization by Powell's method for Gamma unit treatment system Int. J. Radiat. Oncol. Bilo. Phys. 39 247-54 (Pubitemid 27396302)
25. Zaak D, Sroka R, Hoppner M, Khoder W, Reich O, Tritschler S, Muschter R, Knuchel R and Hofstetter A 2003 Photodynamic therapy by means of 5-ALA induced PPIX in human prostate cancer-preliminary results Med. Laser Appl. 18 91-5 (Pubitemid 36505943)
26. Zhu T C and Finlay J C 2010 The role of photodynamic therapy (PDT) physics Med. Phys. 35 3127-36 (Pubitemid 351904517)
27. Zhu T C, Finaly J C and Hahn S M 2005 Determination of the distribution of light, optical properties, drug concentration and tissue oxygenation in vivo in human prostate during motexafin lutetium-mediated photodynamic therapy J. Photochem. Photobiol. 79 231-41 (Pubitemid 40668442)